CEMP - Cempra, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.05
0.00 (0.00%)
At close: 4:00PM EDT

3.05 0.00 (0.00%)
After hours: 4:49PM EDT

Stock chart is not supported by your current browser
Previous Close3.05
Open3.00
Bid3.00 x 400
Ask3.05 x 1100
Day's Range3.00 - 3.10
52 Week Range2.55 - 24.48
Volume694,682
Avg. Volume810,261
Market Cap160.15M
Beta0.73
PE Ratio (TTM)-1.61
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Cempra, Inc. : October 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube19 days ago

    ETFs with exposure to Cempra, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Cempra, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc., NovaBay Pharmaceuticals, Inc., Emergent BioSolutions Inc. and Altimmune, Inc. (JNJ-US, INVA-US, NBY-US, EBS-US and ALT-US) that have also reported for this ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CEMP earnings conference call or presentation 9-Aug-17 12:45pm GMT

    Q2 2017 Cempra Inc Earnings and Update on the Merger with Melinta Therapeutics Inc Call

  • The Wall Street Journal2 months ago

    [$$] Melinta to Secure Public Listing With Cempra Merger

    Melinta Therapeutics Inc. is merging with Cempra Inc., giving shareholders of the venture-backed antibiotics developer a majority stake in the resulting publicly traded company.

  • Associated Press2 months ago

    Cempra reports 2Q loss

    The Chapel Hill, North Carolina-based company said it had a loss of 23 cents per share. The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment ...

  • TheStreet.com2 months ago

    These Two Biotech Stocks Are Going Berserk on Wednesday

    And then there is Mylan.

  • Capital Cube4 months ago

    ETFs with exposure to Cempra, Inc. : June 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cempra, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Cempra, Inc. : May 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
    Capital Cube5 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson and Innoviva, Inc. (JNJ-US and INVA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 4.87 million, Net Earnings ... Read more (Read more...)

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of CEMP earnings conference call or presentation 28-Apr-17 12:45pm GMT

    Q1 2017 Cempra Inc Earnings Call

  • Associated Press6 months ago

    Cempra reports 1Q loss

    On a per-share basis, the Chapel Hill, North Carolina-based company said it had a loss of 44 cents. Losses, adjusted for restructuring costs, were 37 cents per share. The results exceeded Wall Street expectations. ...

  • Investopedia7 months ago

    Cempra Withdraws Solithromycin MAA in Europe

    Cempra stock tumbles as it withdraws the marketing application for pneumonia drug in the EU.

  • TheStreet.com7 months ago

    Biotech Premarket Movers: Cempra, Tesaro, Editas

    Cempra, Tesaro and Editas Medicine were among the biotech stock movers in premarket trading on Tuesday.

  • Capital Cube7 months ago

    ETFs with exposure to Cempra, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube7 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Cempra, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc., KaloBios Pharmaceuticals Inc, Emergent BioSolutions Inc. and PharmAthene, Inc. (JNJ-US, INVA-US, KBIO-US, EBS-US and PIP-US) that have also reported for this ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube7 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Cempra, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc. and Emergent BioSolutions Inc. (JNJ-US, INVA-US and EBS-US) that have also reported for this period. Highlights Year-on-year change in operating cash ... Read more (Read more...)